论文部分内容阅读
目的复检供血者ABO血型,杜绝输血医疗事故发生,确保临床用血安全。方法使用微柱凝胶卡、微柱凝胶中性卡,复检从血站领入临床的成分血(红细胞悬液,血浆、血小板、冷沉淀)ABO血型。结果复检2008-2013年中心血站领入的红细胞悬液37 895 U,有12 U ABO血型正反与血袋血型标签血型不符,差错率0.031%。血浆、血小板、冷沉淀;46 591 U,有17 U反定型鉴定与血袋标签血型不符,差错率0.036%。结论血站发出的各种成分血,血型鉴定结果不是100%正确。把好输血安全质量关。根据卫生部《临床输血技术规范》相关管理规定。过期或其他须查证的情况的血液成分,无条件退回血站,不能用于临床输血治疗,确保临床用血安全。
Objective To review the blood donor ABO blood group, to prevent the occurrence of transfusion medical accidents, to ensure the safety of clinical blood. Methods The micro-column gel card, micro-column gel neutral card, re-examination from the bloodstream into the clinical components of blood (red blood cell suspension, plasma, platelets, cryoprecipitate) ABO blood group. Results The red blood cell suspension 37 895 U from 2008 to 2013 was re-inspected. The positive and negative of 12 U ABO blood group did not match the blood group blood group type with an error rate of 0.031%. Plasma, platelets, cryoprecipitate; 46 591 U, 17 U Reverse-type identification did not match the blood type label, with an error rate of 0.036%. Conclusion All the blood components of the bloodstain are not 100% correct. Good blood transfusion safety and quality control. According to the Ministry of Health “clinical blood transfusion technical specifications” related to the management requirements. Expired or other blood conditions to be verified, blood unconditionally retreated to blood transfusion can not be used to ensure clinical blood safety.